Maxell (6810) Q1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2024 earnings summary
20 Oct, 2026Executive summary
Q1 net sales were ¥32,225 million vs. ¥32,227 million; operating profit rose 57.4% to ¥2,024 million and profit attributable to owners of parent rose 42.6% to ¥2,346 million.
Optics & Systems growth, licensing revenue, business reforms and yen depreciation supported profitability; the FY2024 forecast remained unchanged, with recovery expected from Q3.
Financial highlights
Ordinary profit increased to ¥3,140 million from ¥1,934 million; gross profit rose to ¥7,232 million from ¥7,185 million, while SG&A declined to ¥5,208 million from ¥5,899 million.
Operating profit increased ¥0.7bn YoY, supported by business reform (+¥0.8bn), FX (+¥0.4bn) and cost reductions (+¥0.3bn), offset by quantity variance (-¥0.7bn).
Sales bridge factors were quantity variance -¥1.8bn, price variance +¥0.8bn and FX variance +¥1.0bn, leaving sales essentially unchanged.
Comprehensive income was ¥4,500 million, down 19.5% YoY, reflecting lower other comprehensive income despite higher quarterly profit.
Outlook and guidance
FY2024 forecast was unchanged: net sales ¥133,000 million, operating profit ¥7,500 million, profit attributable to owners of parent ¥5,200 million and EPS ¥113.48.
Economic weakness was expected through Q2, with recovery from Q3; plans included growing automotive-related sales, portfolio reform, cost reductions and reflecting higher costs in selling prices.
Consumer LIB sales were firm in Q1, with slowdown risk after Q2; rechargeable-battery demand was expected to recover from 2H, including medical-use orders.
Construction-tape orders and automotive optical components were expected to recover in 2H; semiconductor DMS was expected to remain firm through component procurement and back-order elimination.
Latest events from Maxell
- Automotive optics and licensing drove 1H profit growth; FY sales guidance was cut.6810
Q2 2024 - Nine-month profit rose on automotive optics and licensing despite lower sales; guidance held.6810
Q3 2024 - Profit rose despite lower sales; FY2025 pairs steady guidance with MEX26 investment.6810
Q4 2024 - Operating profit grew despite lower sales as 150°C battery technology advanced.6810
Q1 2025 - FY2025 sales guidance fell, but the ¥8bn operating profit target was maintained.6810
Q2 2025 - Operating profit rose as Energy and Life Solution offset Optics & Systems; FY guidance is unchanged.6810
Q3 2025 - Operating profit rose 15.3%, while shutdown costs drove attributable profit down 45.8%.6810
Q4 2025 - Energy and Functional Materials growth offset weaker segments; FY2026 guidance remains unchanged.6810
Q1 2026 - Primary batteries and early licensing lifted H1 profit; semiconductor recovery remains delayed.6810
Q2 2026